Fairmount Funds Management

Fairmount is a $6B+ life science investment firm, employing a long-only, event-driven diligence process. As founders, operators, and investors, Fairmount seeks to identify biotechnology investments at their earliest stage of material de-risking, with the goal of building a concentrated portfolio of best-in-class commercial and research enterprises. Fairmount’s investment universe is comprised of public and private biotech companies, as well as the creation of compelling new opportunities through the firm’s drug discovery and company formation efforts.